Vessel ultrastructure in APP23 transgenic mice after passive anti-Aβ immunotherapy and subsequent intracerebral hemorrhage
- 28 February 2007
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 28 (2) , 202-212
- https://doi.org/10.1016/j.neurobiolaging.2005.12.003
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Cerebral amyloid angiopathy: major contributor or decorative response to Alzheimer’s disease pathogenesisNeurobiology of Aging, 2004
- Amyloid-β Immunization Effectively Reduces Amyloid Deposition in FcRγ-/-Knock-Out MiceJournal of Neuroscience, 2003
- Cerebrovascular requirement for sealant, anti-coagulant and remodeling molecules that allow for the maintenance of vascular integrity and blood supplyBrain Research Reviews, 2003
- Cerebral Hemorrhage and Amyloid-βScience, 2003
- Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathologyProceedings of the National Academy of Sciences, 2003
- Non-Fc-Mediated Mechanisms Are Involved in Clearance of Amyloid-βIn Vivoby ImmunotherapyJournal of Neuroscience, 2002
- Reduced effectiveness of Aβ1-42 immunization in APP transgenic mice with significant amyloid depositionNeurobiology of Aging, 2001
- Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapyNature Medicine, 2001
- Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer diseaseNature Medicine, 2000
- Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloidProceedings of the National Academy of Sciences, 1999